EmbectaMEX:EMBC 53 FCF Yield % is 99.48 as of Jun. 27, 2026, which is 1230% above its 10-year median of 7.48. GuruFocus rates MEX:EMBC with a GF Score™ of 53/100 and a GF Value™ of MXN2,033.47. The stock has 6 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Embecta ranks better than 99.77% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Embecta's Trailing 12-Month Free Cash Flow is MXN3,798 Mil, and Market Cap is MXN3,627 Mil. Therefore, Embecta's FCF Yield % for today is 99.48%.
The historical rank and industry rank for Embecta's FCF Yield % or its related term are showing as below:
MEX:EMBC'
s FCF Yield % Range Over the Past 10 Years
Min: -4.24 Med: 7.48 Max: 111.35
Current: 99.48
During the past 7 years, the highest FCF Yield % of Embecta was 111.35%. The lowest was -4.24%. And the median was 7.48%.
MEX:EMBC's FCF Yield % is ranked better than 99.77% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs MEX:EMBC: 99.48
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Embecta FCF Yield % Related Terms
Embecta FCF Yield % Historical Data
* Premium members only.
The historical data trend for Embecta's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:EMBC vs PDEX, STXS, SMTI: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Embecta's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embecta FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Embecta's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta (MEX:EMBC) has a FCF Yield % of 99.48 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Embecta and its competitors. This is 1230% above median its historical median of 7.48. According to the industry distribution chart, Embecta ranks #2 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 0.2%.
Is Embecta's FCF Yield % too high?
Embecta's current FCF Yield % of 99.48 is 1230% above median its 10-year median of 7.48. Based on the distribution chart, Embecta ranks #2 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Embecta has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Embecta's FCF Yield % compare to PDEX and STXS?
According to the Medical Devices & Instruments industry distribution chart, Embecta ranks #2 out of 855 companies for FCF Yield %. This places Embecta in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Embecta and its competitors. Embecta's current FCF Yield % is 99.48, which is 1230% above median its own 10-year median of 7.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embecta stock overvalued right now?
Embecta (MEX:EMBC) has a current FCF Yield % of 99.48. The stock's GF Value™ is MXN2,033.47, compared to a current price of MXN497.96 — trading 75.5% below its estimated fair value. The current FCF Yield % is 99.48, which is 1230% above median its 10-year median of 7.48. Embecta's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Embecta (MEX:EMBC), the current FCF Yield % is 99.48 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embecta (MEX:EMBC) Overvalued in 2026?
Based on GuruFocus' analysis, Embecta stock appears to be undervalued.
The current stock price of MXN497.96 is trading 75.5% below its estimated GF Value™ of MXN2,033.47.
Key valuation signals for MEX:EMBC:
FCF Yield %: 99.48 (1230% above median its 10-year median of 7.48)
GF Value™: MXN2,033.47 vs. price of MXN497.96 (75.5% below fair value)
No single metric tells the full story. See the MEX:EMBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
53GF Score
Get the complete analysis for MEX:EMBC
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EMBC has been successfully added to your 
